Desreux Joëlle A C
Department of Senology, CHU Liège, Avenue de l'Hôpital 1, 4000 Liège, Belgium.
Eur J Obstet Gynecol Reprod Biol. 2018 Nov;230:208-211. doi: 10.1016/j.ejogrb.2018.05.018. Epub 2018 May 24.
Breast cancer is the leading cause of death by cancer in women aged less than 40. However, organized screening of young healthy women has been recognized as inefficient and even deleterious by most experts [1], and should not been offered. Individualized screening, targeting only some young high-risk women, may be beneficial although no randomized trial has proven an impact on breast cancer mortality. All recommendations are based on expert's opinions. This review offers a toned overview of these recommendations and underlines the need of careful information and shared decision with each patient.
乳腺癌是40岁以下女性癌症死亡的主要原因。然而,大多数专家认为,对年轻健康女性进行有组织的筛查效率低下甚至有害[1],不应进行。仅针对一些年轻高危女性的个体化筛查可能有益,尽管尚无随机试验证明其对乳腺癌死亡率有影响。所有建议均基于专家意见。本综述对这些建议进行了全面概述,并强调了向每位患者提供详细信息并共同做出决策的必要性。